Real-World Evidence 2022: a sneak peek interview with Leslie Galloway

In the run up to Real-World Evidence Live: Rare Diseases and Innovative Therapies (London, UK; 29–30 June 2022), we’re giving you a preview of what you can experience at the event, including core themes such as reimbursement, machine learning and patient-first practices. One of our speakers, Leslie Galloway of Ethical Medicines Industry Group (EMIG, London, UK), has sat down with us to talk about his upcoming feature, ‘Accelerated regulatory approval in 2022 and beyond: managing uncertainty with the impact of Brexit and COVID’, which you can attend on day 2 of Real-World Evidence Live 2022. Leslie has built a successful...